Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.-论文-万方医学网

第一作者： Jeffrey D,Bradley

第一单位： Washington University, St Louis, MO, USA. Electronic address: jbradley@radonc.wustl.edu.

作者： Jeffrey D,Bradley ^[1] ; Rebecca,Paulus ^[2] ; Ritsuko,Komaki ^[3] ; Gregory,Masters ^[4] ; George,Blumenschein ^[3] ; Steven,Schild ^[5] ; Jeffrey,Bogart ^[6] ; Chen,Hu ^[2] ; Kenneth,Forster ^[7] ; Anthony,Magliocco ^[7] ; Vivek,Kavadi ^[8] ; Yolanda I,Garces ^[9] ; Samir,Narayan ^[10] ; Puneeth,Iyengar ^[11] ; Cliff,Robinson ^[12] ; Raymond B,Wynn ^[13] ; Christopher,Koprowski ^[14] ; Joanne,Meng ^[15] ; Jonathan,Beitler ^[16] ; Rakesh,Gaur ^[17] ; Walter,Curran ^[16] ; Hak,Choy ^[11]

作者单位： Washington University, St Louis, MO, USA. Electronic address: jbradley@radonc.wustl.edu. ^[1] Radiation Therapy Oncology Group-Statistical Center, Philadelphia, PA, USA. ^[2] The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[3] Christiana Care/Helen Graham Medical Center, Newark, DE, USA. ^[4] Mayo Clinic, Scottsdale, AZ, USA. ^[5] SUNY Upstate Medical University, Syracuse NY, USA. ^[6] H Lee Moffitt Cancer Center, Tampa, FL, USA. ^[7] USON- Texas Oncology-Sugarland, Sugarland, TX, USA. ^[8] Mayo Clinic, Rochester, MN, USA. ^[9] Michigan Cancer Research Consortium CCOP, Ypsilanti, MI, USA. ^[10] University of Texas Southwestern, Dallas, TX, USA. ^[11] Washington University, St Louis, MO, USA. ^[12] UPMC-Shadyside Hospital, Pittsburgh, PA, USA. ^[13] Christiana Care Health CCOP, Newark, DE, USA. ^[14] The Ottawa Hospital Cancer Centre, Ottawa, Canada. ^[15] Emory University, Atlanta, GA, USA. ^[16] Kansas City CCOP, Kansas City, MO, USA. ^[17]

医学主题词腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);癌, 大细胞(Carcinoma, Large Cell);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);癌, 鳞状细胞(Carcinoma, Squamous Cell);综合疗法(Combined Modality Therapy);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤分期(Neoplasm Staging);紫杉酚(Paclitaxel);预后(Prognosis);放射治疗剂量(Radiotherapy Dosage);放射疗法, 适形(Radiotherapy, Conformal);存活率(Survival Rate)

DOI 10.1016/S1470-2045(14)71207-0

PMID 25601342

发布时间 2024-01-09

检索历史清除

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

The Lancet. Oncology

相似文献

同项目论文

The Lancet. Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

The Lancet. Oncology

相似文献

同项目论文

The Lancet. Oncology

相关期刊

检索历史清除